Beyond Air, Inc. Increase (Decrease) in Accounts Payable
Beyond Air, Inc. (XAIR) reported Increase (Decrease) in Accounts Payable of -$321.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13
- Beyond Air, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$321.00K.
- Beyond Air, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $392.00K, a 361.18% increase year-over-year.
- Beyond Air, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$90.00K, a 110.83% decline year-over-year.
- Beyond Air, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $673.00K.
- Beyond Air, Inc. increase (decrease) in accounts payable for fiscal 2026 was $267.00K, a 33.08% decline from fiscal 2025.
- Beyond Air, Inc. increase (decrease) in accounts payable for fiscal 2025 was $399.00K.
- Beyond Air, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$467.00K, a 155.73% decline from fiscal 2023.
- Beyond Air, Inc. increase (decrease) in accounts payable for fiscal 2023 was $838.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 8 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$321.00K 10-Q · filed 2026-08-13 | $71.00K derived: sum of 2 quarters · filed 2026-08-13 | -$19.00K derived: sum of 3 quarters · filed 2026-08-13 | $654.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $302.00K derived: sum of 2 quarters · filed 2026-06-26 | $975.00K derived: sum of 3 quarters · filed 2026-06-26 | $267.00K 10-K · filed 2026-06-26 | |
| 2025-12-31 | -$90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13 | $583.00K derived: sum of 2 quarters · filed 2026-02-13 | -$125.00K 10-Q · filed 2026-02-13 | -$40.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | $673.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | -$35.00K 10-Q · filed 2025-11-10 | $50.00K derived: sum of 3 quarters · filed 2026-08-13 | $881.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$708.00K 10-Q · filed 2026-08-13 | -$623.00K derived: sum of 2 quarters · filed 2026-08-13 | $208.00K derived: sum of 3 quarters · filed 2026-08-13 | -$800.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $916.00K derived: sum of 2 quarters · filed 2026-06-26 | -$92.00K derived: sum of 3 quarters · filed 2026-06-26 | $399.00K 10-K · filed 2026-06-26 | |
| 2024-12-31 | $831.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13 | -$177.00K derived: sum of 2 quarters · filed 2026-02-13 | $314.00K 10-Q · filed 2026-02-13 | -$493.00K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | -$517.00K 10-Q · filed 2025-11-10 | -$1.32M derived: sum of 3 quarters · filed 2025-11-10 | -$2.26M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | $491.00K 10-Q · filed 2025-08-12 | -$316.00K derived: sum of 2 quarters · filed 2025-08-12 | -$1.25M derived: sum of 3 quarters · filed 2025-08-12 | $330.00K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$807.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | -$1.74M derived: sum of 2 quarters · filed 2025-06-20 | -$161.00K derived: sum of 3 quarters · filed 2025-06-20 | -$467.00K 10-K · filed 2025-06-20 | |
| 2023-12-31 | -$937.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-10 | $646.00K derived: sum of 2 quarters · filed 2025-02-10 | $340.00K 10-Q · filed 2025-02-10 | $1.52M derived: sum of 4 quarters · filed 2025-02-10 | |
| 2023-09-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | $1.28M 10-Q · filed 2024-11-12 | $2.45M derived: sum of 3 quarters · filed 2024-11-12 | $1.25M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$306.00K 10-Q · filed 2024-08-06 | $870.00K derived: sum of 2 quarters · filed 2024-08-06 | -$332.00K derived: sum of 3 quarters · filed 2024-08-06 | $696.00K derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | -$26.00K derived: sum of 2 quarters · filed 2024-06-24 | $1.00M derived: sum of 3 quarters · filed 2024-06-24 | $838.00K 10-K · filed 2024-06-24 | |
| 2022-12-31 | -$1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | -$174.00K derived: sum of 2 quarters · filed 2024-02-12 | -$338.00K 10-Q · filed 2024-02-12 | -$951.00K derived: sum of 4 quarters · filed 2024-02-12 | |
| 2022-09-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $864.00K 10-Q · filed 2023-11-13 | $251.00K derived: sum of 3 quarters · filed 2023-11-13 | -$363.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$164.00K 10-Q · filed 2023-08-10 | -$777.00K derived: sum of 2 quarters · filed 2023-08-10 | -$1.39M derived: sum of 3 quarters · filed 2023-08-10 | ||
| 2022-03-31 | -$613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | -$1.23M derived: sum of 2 quarters · filed 2023-06-22 | -$327.00K 10-K · filed 2023-06-22 | ||
| 2021-12-31 | -$614.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-10 | $286.00K 10-Q · filed 2023-02-10 | |||
| 2021-09-30 | $900.00K 10-Q · filed 2022-11-08 | ||||
| 2016-12-31 | $40.96K 10-K · filed 2017-03-31 | ||||
| 2015-12-31 | $750.00 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |